Director Xie Bing increases his holdings of SBP GROUP (01177) by 2 million shares at an approximate price of HKD 5.52 per share.
On April 29, Executive Director Xie Bing increased his holdings of China Biopharmaceuticals (01177) by 2 million shares, with a price of 5.5235 Hong Kong dollars per share, for a total amount of 11.047 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on April 29, executive director Xie Bing increased his holdings of SBP GROUP (01177) by 2 million shares, with a price of HK$5.5235 per share, for a total amount of HK$11.047 million. After the increase, the new total number of shares held is approximately 1.694 billion shares, with a holding percentage of 9.04%.
Related Articles
ELIFE Holdings (00223) completed the placement of a total of 271 million shares, raising approximately 27.1 million Hong Kong dollars.
GigaDevice Semiconductor Inc. (03986) released its first quarter results with a net profit attributable to shareholders of approximately 1.461 billion yuan, a year-on-year increase of 522.79%.
ANDRE JUICE (02218) announces its first quarter performance with a net profit attributable to the parent company of 72.70 million RMB, a decrease of 15.52% compared to the same period last year.
ELIFE Holdings (00223) completed the placement of a total of 271 million shares, raising approximately 27.1 million Hong Kong dollars.
GigaDevice Semiconductor Inc. (03986) released its first quarter results with a net profit attributable to shareholders of approximately 1.461 billion yuan, a year-on-year increase of 522.79%.
ANDRE JUICE (02218) announces its first quarter performance with a net profit attributable to the parent company of 72.70 million RMB, a decrease of 15.52% compared to the same period last year.
RECOMMEND
